|
Size, n
|
75
|
41
| |
|
Demographics
|
|
Age, year, mean (SD)
|
70.67 (13.31)
|
69.37 (8.60)
|
0.574d
|
|
Sex, male, n (%)
|
41 (54.7)
|
24 (58.5)
|
0.837c
|
|
Ethnicity, Caucasian, n (%)
|
53 (70.7)
|
36 (87.8)
|
0.063c
|
|
Body Mass Index, median [Q1, Q3]
|
25.93 [23.07, 28.41]
|
26.36 [24.74, 29.58]
|
0.177b
|
|
Chronic comorbidities, n (%)
|
|
COPD
|
26 (34.7)
|
4 (9.8)
|
0.007c
|
|
Cardiovascular disease
|
58 (77.3)
|
25 (61.0)
|
0.099c
|
|
Diabetes
|
19 (25.3)
|
4 (9.8)
|
0.077c
|
|
Malignancy
|
20 (26.7)
|
8 (19.5)
|
0.526c
|
|
Chronic renal disease
|
7 (9.3)
|
1 (2.4)
|
0.309c
|
|
Immunosuppressiona
|
4 (5.3)
|
2 (4.9)
|
0.99c
|
|
Disease severity, median [Q1, Q3]
|
|
PSI score
|
4.00 [3.00, 4.00]
|
–
| |
|
SOFA score
|
0.00 [0.00, 1.00]
|
–
| |
|
Causal pathogen, n (%)
| |
–
| |
|
Streptococcus pneumoniae
|
10 (13.33)
|
–
| |
|
Haemophilus influenzae
|
7 (9.33)
|
–
| |
|
Staphylococcus aureus
|
4 (5.33)
|
–
| |
|
Influenza A virus
|
6 (8)
|
–
| |
|
Influenza B virus
|
3 (4)
|
–
| |
|
Rhinovirus
|
3 (4)
|
–
| |
|
Coronavirus type NL63
|
1 (1.33)
|
–
| |
|
Respiratory syncytial virus
|
2 (2.67)
|
–
| |
|
Human metapneumovirus
|
2 (2.67)
|
–
| |
|
Parainfluenza virus 1–4
|
2 (2.67)
|
–
| |
|
No causative pathogen identified
|
39 (52)
|
–
| |
|
Outcome
|
|
ICU admission, n (%)
|
5 (6.7)
|
–
| |
|
Hospital LoS, days, median [Q1, Q3]
|
5.00 [3.00, 8.75]
|
–
| |
|
Hospital mortality, n (%)
|
1 (1.4)
|
–
| |
|
Day 28 mortality, n (%)
|
4 (6.1)
|
–
| |
